Mark A. Hillman Holdings Activity

Hillman Value Fund Portfolio 13F

Hillman Value Fund has disclosed a total of 19 changes to the portfolio in the latest (2023 Q4) SEC report(s): increased the number of shares of 3, bought 3 totally new, decreased the number of shares of 12 and completely sold out 1 position(s).

What stocks is Mark A. Hillman buying now?

In the recent quarter Mark A. Hillman has bought 6 securities out of which top 5 purchases (by % change to portfolio) are (EL) ESTEE LAUDER COMPANIES-CL A (new buy), (KMX) CARMAX INC (new buy), (PFE) PFIZER INC (new buy), (UMBXX) MONEY MARKET FIDUCIA (added shares +25.72%) and (JWN) NORDSTROM INC (added shares +33.3%).

What does Mark A. Hillman invest in?

Mark A. Hillman's top 5 holdings (by % of portfolio) are (UMBXX) MONEY MARKET FIDUCIA (3.9%), (SPG) SIMON PROPERTY GROUP INC (3.07%), (JWN) NORDSTROM INC (3%), (CRM) SALESFORCECOM INC (2.93%) and (BK) BANK OF NEW YORK MELLON CORP (2.91%).

In the latest report(s) the following changes have been made to the top investments: (UMBXX) MONEY MARKET FIDUCIA (added shares +25.72%) and (JWN) NORDSTROM INC (added shares +33.3%).

2021 Q1 (31 results)
JWN
-100.00%
-223,000
-4.03%
$31.21
31.05% $21.52
0.00%
BAC
-100.00%
-100,000
-1.75%
$30.31
30.98% $39.70
0.00%
GE
-100.00%
-43,871
-3.16%
$86.40
93.67% $167.33
0.00%
JPM
-100.00%
-24,887
-2.69%
$127.07
57.95% $200.71
0.00%
GS
-100.00%
-11,800
-1.80%
$263.71
74.88% $461.18
0.00%
MSFT
+14.71%
+1,325
+0.34%
$235.77
82.45% $430.16
2.66%
BA
+20.88%
+3,800
+0.56%
$254.72
31.49% $174.52
3.24%
GD
+18.32%
+4,800
+0.50%
$181.56
65.03% $299.62
3.26%
BIIB
+37.88%
+5,000
+0.81%
$279.75
22.14% $217.81
2.95%
DD
+10.34%
+3,090
+0.27%
$77.28
4.97% $81.12
2.86%
RTX
+9.93%
+6,157
+0.28%
$77.27
37.53% $106.27
3.05%
MRK
+11.70%
+6,600
+0.29%
$77.09
67.97% $129.49
2.81%
META
+72.73%
+8,000
+1.36%
$294.53
62.37% $478.22
3.24%
BK
+8.00%
+7,880
+0.22%
$47.29
24.95% $59.09
2.95%
CMP
+15.00%
+9,000
+0.33%
$62.72
80.04% $12.52
2.50%
BDX
+100.00%
+11,640
+1.69%
$243.15
5.91% $228.79
3.38%
CVS
+22.22%
+14,000
+0.61%
$75.23
26.17% $55.54
3.35%
CSCO
+17.78%
+16,000
+0.48%
$51.71
10.23% $46.42
3.17%
KHC
+21.67%
+26,000
+0.60%
$40.00
10.38% $35.85
3.38%
BUD
+53.02%
+29,800
+1.08%
$62.85
3.48% $65.04
3.13%
BMY
+69.57%
+32,000
+1.17%
$63.13
34.67% $41.24
2.85%
AMZN
buy
+32,000
+2.86%
$154.70
16.84% $180.75
2.86%
VZ
+59.62%
+38,100
+1.28%
$58.15
31.66% $39.74
3.43%
K
+70.52%
+39,700
+1.45%
$63.30
3.57% $61.04
3.52%
T
+30.53%
+40,000
+0.70%
$30.27
42.19% $17.50
2.99%
PAA
+8.93%
+27,249
+0.26%
$9.10
87.36% $17.05
3.21%
GOOGL
buy
+32,199
+3.34%
$103.13
69.69% $174.99
3.34%
PFE
+59.80%
+33,320
+1.25%
$36.23
20.29% $28.88
3.33%
MMP
buy
+115,000
+2.88%
$43.36
59.13% $69.00
2.88%
GSK
buy
+120,320
+3.30%
$44.61
1.14% $45.12
3.30%
UMBXX
+270.12%
+3,347,287
+1.94%
$1.00
-
2.65%
2020 Q4 (18 results)
UMBXX
-74.80%
-3,678,575
-2.79%
$1.00
-
0.94%
NKE
-100.00%
-28,000
-2.66%
$125.54
26.92% $91.75
0.00%
GD
+13.91%
+3,200
+0.36%
$148.82
101.33% $299.62
2.96%
JPM
+22.00%
+4,488
+0.64%
$127.07
57.95% $200.71
0.00%
INTC
+10.00%
+7,200
+0.27%
$49.82
38.34% $30.72
2.99%
K
+21.60%
+10,000
+0.47%
$62.23
1.91% $61.04
2.66%
VZ
+24.32%
+12,500
+0.56%
$58.75
32.36% $39.74
2.85%
RTX
+26.51%
+13,000
+0.70%
$71.51
48.61% $106.27
3.36%
CVS
+26.00%
+13,000
+0.67%
$68.30
18.68% $55.54
3.26%
PFE
+22.09%
+18,000
+0.50%
$36.81
21.54% $28.88
2.78%
MRK
+54.95%
+20,000
+1.24%
$81.80
58.30% $129.49
3.50%
XOM
+27.06%
+23,000
+0.72%
$41.22
175.16% $113.42
3.37%
WFC
+17.42%
+14,260
+0.53%
$30.18
99.50% $60.21
3.55%
T
+27.18%
+28,000
+0.61%
$28.76
39.15% $17.50
2.86%
KHC
+31.87%
+19,285
+0.76%
$34.66
3.43% $35.85
3.15%
EPD
+29.09%
+48,000
+0.71%
$19.59
44.00% $28.21
3.16%
PAA
+18.39%
+52,635
+0.54%
$8.24
106.92% $17.05
3.50%
BK
buy
+100,000
+3.22%
$42.44
39.23% $59.09
3.22%
49 of 221

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.